Exportar registro bibliográfico


Metrics:

Estrogen receptor 1 (ESR1) regulates VEGFA in adipose tissue (2017)

  • Authors:
  • USP affiliated authors: FREITAS, HELAYNE SOARES DE - ICB ; MACHADO, UBIRATAN FABRES - ICB
  • Unidade: ICB
  • DOI: 10.1038/s41598-017-16686-7
  • Assunto: FISIOLOGIA
  • Language: Inglês
  • Imprenta:
  • Source:
  • Acesso à fonteDOI
    Informações sobre o DOI: 10.1038/s41598-017-16686-7 (Fonte: oaDOI API)
    • Este periódico é de acesso aberto
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: gold
    • Licença: cc-by

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      FATIMA, L. A.; CAMPELLO, R. S.; SANTOS, R. de Souza; et al. Estrogen receptor 1 (ESR1) regulates VEGFA in adipose tissue. Scientific Reports, London, Nature Publishing Group, v. 7, n. 1, p. 1-14, 2017. Disponível em: < http://dx.doi.org/10.1038/s41598-017-16686-7 > DOI: 10.1038/s41598-017-16686-7.
    • APA

      Fatima, L. A., Campello, R. S., Santos, R. de S., Freitas, H. S., Frank, A. P., Machado, U. F., & Clegg, D. J. (2017). Estrogen receptor 1 (ESR1) regulates VEGFA in adipose tissue. Scientific Reports, 7( 1), 1-14. doi:10.1038/s41598-017-16686-7
    • NLM

      Fatima LA, Campello RS, Santos R de S, Freitas HS, Frank AP, Machado UF, Clegg DJ. Estrogen receptor 1 (ESR1) regulates VEGFA in adipose tissue [Internet]. Scientific Reports. 2017 ; 7( 1): 1-14.Available from: http://dx.doi.org/10.1038/s41598-017-16686-7
    • Vancouver

      Fatima LA, Campello RS, Santos R de S, Freitas HS, Frank AP, Machado UF, Clegg DJ. Estrogen receptor 1 (ESR1) regulates VEGFA in adipose tissue [Internet]. Scientific Reports. 2017 ; 7( 1): 1-14.Available from: http://dx.doi.org/10.1038/s41598-017-16686-7

    Referências citadas na obra
    Cao, Y. Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases. Nat Rev Drug Discov. 9, 107–115 (2010).
    Sun, K. et al. Dichotomous effects of VEGF-A on adipose tissue dysfunction. Proc Natl Acad Sci USA 109, 5874–5879 (2012).
    Kim, J. Y. et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest. 117, 2621–2637 (2007).
    Gustafson, B., Hedjazifar, S., Gogg, S., Hammarstedt, A. & Smith, U. Insulin resistance and impaired adipogenesis. Trends Endocrinol Metab. 26, 193–200 (2015).
    Zhang, Q. X. et al. Vascular endothelial growth factor is the major angiogenic factor in omentum: mechanism of the omentum-mediated angiogenesis. J Surg Res. 67, 147–154 (1997).
    Reinders, M. E. et al. Proinflammatory functions of vascular endothelial growth factor in alloimmunity. J Clin Invest. 112, 1655–1665 (2003).
    Rupnick, M. A. et al. Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci USA 99, 10730–10735 (2002).
    Daquinag, A. C., Zhang, Y. & Kolonin, M. G. Vascular targeting of adipose tissue as an anti-obesity approach. Trends Pharmacol Sci. 32(5), 300–307 (2011).
    Stubbins, R. E., Holcomb, V. B., Hong, J. & Núñez, N. P. Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance. Eur J Nutr. 51, 861–870 (2012).
    Tchernof, A. et al. Ovarian hormone status and abdominal visceral adipose tissue metabolism. J Clin Endocrinol Metab. 89, 425–3430 (2004).
    Applanat, M. P., Buteau-Lozano, H., Herve, M. A. & Corpet, A. Vascular endothelial growth factor is a target gene for estrogen receptor and contributes to breast cancer progression. Adv Exp Med Biol. 617, 437–444 (2008).
    Clegg, D. J., Brown, L. M., Woods, S. C. & Benoit, S. C. Gonadal hormones determine sensitivity to central leptin and insulin. Diabetes. 55, 978–987 (2006).
    Davis, K. E. et al. The sexually dimorphic role of adipose and adipocyte estrogen receptors in modulating adipose tissue expansion, inflammation, and fibrosis. Mol Metab. 2, 227–242 (2013).
    Ribas, V. et al. Impaired oxidative metabolism and inflammation are associated with insulin resistance in ERalpha-deficient mice. Am J Physiol Endocrinol Metab. 298, E304–319 (2010).
    Campbell, S. E. & Febbraio, M. A. Effect of the ovarian hormones on GLUT4 expression and contraction-stimulated glucose uptake. Am J Physiol Endocrinol Metab. 282, E1139–1146 (2002).
    Davis, S. et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell. 87, 1161–1169 (1996).
    Palmer, B. F. & Clegg, D. J. The sexual dimorphism of obesity. Mol Cell Endocrinol. 402, 113–119 (2015).
    Grandien, K. Determination of transcription start sites in the human estrogen receptor gene and identification of a novel, tissue-specific, estrogen receptor-mRNA isoform. Mol Cell Endocrinol. 116, 207–212 (1996).
    Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S. & Gustafsson, J. A. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 93, 5925–5930 (1996).
    Saunders, P. T., Maguire, S. M., Gaughan, J. & Millar, M. R. Expression of oestrogen receptor beta (ER beta) in multiple rat tissues visualised by immunohistochemistry. J Endocrinol. 154, R13–16 (1997).
    Revankar, C. M., Cimino, D. F., Sklar, L. A., Arterburn, J. B. & Prossnitz, E. R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 307, 1625–1630 (2005).
    Kuiper, G. G. et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology. 138, 863–870 (1997).
    Nilsson, S. et al. Mechanisms of estrogen action. Physiol Rev. 81, 1535–1565 (2001).
    Mauvais-Jarvis, F., Clegg, D. J. & Hevener, A. L. The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev. 34, 309–338 (2013).
    Helguero, L. A., Faulds, M. H., Gustafsson, J. A. & Haldosén, L. A. Estrogen receptors alfa (ERalpha) and beta (ERbeta) differentially regulate proliferation and apoptosis of the normal murine mammary epithelial cell line HC11. Oncogene. 24, 6605–6616 (2005).
    Hammes, S. R. & Levin, E. R. Extranuclear steroid receptors: nature and actions. Endocr Rev. 28, 726–741 (2007).
    Nilsson, S. & Gustafsson, J. A. Estrogen receptor transcription and transactivation: Basic aspects of estrogen action. Breast Cancer Res. 2, 360–366 (2000).
    Kazi, A. A. & Koos, R. D. Estrogen-induced activation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor expression, and edema in the uterus are mediated by the phosphatidylinositol 3-kinase/Akt pathway. Endocrinology. 148, 2363–2374 (2007).
    Pedersen, S. B. et al. Identification of oestrogen receptors and oestrogen receptor mRNA in human adipose tissue. Eur J Clin Invest. 26, 262–269 (1996).
    Dieudonné, M. N., Leneveu, M. C., Giudicelli, Y. & Pecquery, R. Evidence for functional estrogen receptors alpha and beta in human adipose cells: regional specificities and regulation by estrogens. Am J Physiol Cell Physiol. 286, C655–661 (2004).
    Barros, R. P., Gabbi, C., Morani, A., Warner, M. & Gustafsson, J. A. Participation of ERalpha and ERbeta in glucose homeostasis in skeletal muscle and white adipose tissue. Am J Physiol Endocrinol Metab. 297, E124–133 (2009).
    Campello, R. S. et al. Estrogen Receptor 1 Agonist PPT Stimulates Slc2a4 Gene Expression and Improves Insulin-Induced Glucose Uptake in Adipocytes. Curr Top Med Chem. 12, 2059–2069 (2012).
    Heine, P. A., Taylor, J. A., Iwamoto, G. A., Lubahn, D. B. & Cooke, P. S. Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci USA 97, 12729–12734 (2000).
    Barros, R. P., Machado, U. F., Warner, M. & Gustafsson, J. A. Muscle GLUT4 regulation by estrogen receptors ERbeta and ERalpha. Proc Natl Acad Sci USA 103, 1605–1608 (2006).
    Takeda, K. et al. Progressive development of insulin resistance phenotype in male mice with complete aromatase (CYP19) deficiency. J Endocrinol. 176, 237–246 (2003).
    Jones, M. E. et al. Aromatase-deficient (ArKO) mice have a phenotype of increased adiposity. Proc Natl Acad Sci USA 97, 12735–12740 (2000).
    Barros, R. P., Machado, U. F. & Gustafsson, J. A. Estrogen receptors: new players in diabetes mellitus. Trends Mol Med. 12, 425–431 (2006).
    Sengupta, K., Banerjee, S., Saxena, N. & Banerjee, S. K. Estradiol-induced vascular endothelial growth factor-A expression in breast tumor cells is biphasic and regulated by estrogen receptor-alpha dependent pathway. Int J Oncol. 22, 609–614 (2003).
    Stoner, M. et al. Estrogen regulation of vascular endothelial growth factor gene expression in ZR-75 breast cancer cells through interaction of estrogen receptor alpha and SP proteins. Oncogene. 23, 1052–1063 (2004).
    Ma, Y. L. et al. The effects of different doses of estradiol (E2) on cerebral ischemia in an in vitro model of oxygen and glucose deprivation and reperfusion and in a rat model of middle carotid artery occlusion. BMC Neurosci. 14, 118 (2013).
    Henninger, A. M., Eliasson, B., Jenndahl, L. E. & Hammarstedt, A. Adipocyte hypertrophy, inflammation and fibrosis characterize subcutaneous adipose tissue of healthy, non-obese subjects predisposed to type 2 diabetes. PLoS One. 9, 105262 (2014).
    Barros, R. P. & Gustafsson, J. Estrogen receptors and the metabolic network. Cell Metab. 14, 289–299 (2011).
    Pfeilschifter, J., Köditz, R., Pfohl, M. & Schatz, H. Changes in proinflammatory cytokine activity after menopause. Endocr Rev. 23, 90–119 (2002).
    Xue, Y. et al. Hypoxia-independent angiogenesis in adipose tissues during cold acclimation. Cell Metab. 9, 99–109 (2009).
    Park, Y. M., Erickson, C., Bessesen, D., Van Pelt, R. E. & Cox-York, K. Age- and menopause-related differences in subcutaneous adipose tissue estrogen receptor mRNA expression. Steroids. 121, 17–21 (2017).
    Broekmans, F. J., Soules, M. R. & Fauser, B. C. Ovarian aging: mechanisms and clinical consequences. Endocr Rev. 30, 465–493 (2009).
    Buteau-Lozano, H., Ancelin, M., Lardeux, B., Milanini, J. & Perrot-Applanat, M. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta. Cancer Res. 62, 4977–4984 (2002).
    Kazi, A. A., Jones, J. M. & Koos, R. D. Chromatin immunoprecipitation analysis of gene expression in the rat uterus in vivo: estrogen-induced recruitment of both estrogen receptor alpha and hypoxia-inducible factor 1 to the vascular endothelial growth factor promoter. Mol Endocrinol. 19, 2006–2019 (2005).
    Ledoux., S. et al. Angiogenesis associated with visceral and subcutaneous adipose tissue in severe human obesity. Diabetes. 57, 3247–3257 (2008).
    Forsythe, J. A. et al. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol. 16, 4604–4613 (1996).
    George, A. L., Rajoria, S., Suriano, R., Mittleman, A. & Tiwari, R. K. Hypoxia and estrogen are functionally equivalent in breast cancer-endothelial cell interdependence. Mol Cancer. 11, 80 (2012).
    Cao, Y. Angiogenesis modulates adipogenesis and obesity. J Clin Invest. 117, 2362–2368 (2007).
    Hausman, G. J. & Richardson, R. L. Adipose tissue angiogenesis. J Anim Sci. 82, 925–934 (2004).
    Schofield, C. J. & Ratcliffe, P. J. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol. 5, 343–354 (2004).
    Yang, J. et al. Estrogen receptor-α directly regulates the hypoxia-inducible fator 1 pathway associated with antiestrogen response in breast cancer. Proc Natl Acad Sci USA 112, 15172–7 (2015).
    Kim, M. et al. ERα upregulates Phd3 to ameliorate HIF-1 induced fibrosis and inflammation in adipose tissue. Mol Metab. 3, 642–651 (2014).
    Zhang, X. et al. Adipose tissue-specific inhibition of hypoxia-inducible factor 1{alpha} induces obesity and glucose intolerance by impeding energy expenditure in mice. J Biol Chem. 285, 32869–32877 (2010).
    Campello, R. et al. Estradiol-induced regulation of GLUT4 in 3T3-L1 cells: involvement of ESR1 and AKT activation. J Mol Endocrinol. 59, 257–268 (2017).
    Corvera, S. & Gealekman, O. Adipose tissue angiogenesis: impact on obesity and type-2 diabetes. Biochim Biophys Acta. 1842, 463–472 (2014).
    Terman, B. I. et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun. 187, 1579–1586 (1992).
    Elias, I. et al. Adipose tissue overexpression of vascular endothelial growth factor protects against diet-induced obesity and insulin resistance. Diabetes. 61, 1801–1813 (2012).
    Sun, K. et al. Brown adipose tissue derived VEGF-A modulates cold tolerance and energy expenditure. Mol Metab. 3, 474–483 (2014).
    Pedram, A., Razandi, M., Blumberg, B. & Levin, E. R. Membrane and nuclear estrogen receptor α collaborate to suppress adipogenesis but not triglyceride content. FASEB J. 30, 230–240 (2016).
    Sung, H. K. et al. Adipose Vascular Endothelial Growth Factor Regulates Metabolic Homeostasis through Angiogenesis. Cell Metab. 17, 61–72 (2013).
    Chamberlain, L. H. Inhibition of isoprenoid biosynthesis causes insulin resistance in 3T3-L1 adipocytes. FEBS Lett. 507, 357–361 (2001).
    Furuya, D. T., Poletto, A. C., Freitas, H. S. & Machado, U. F. Inhibition of cannabinoid CB1 receptor upregulates Slc2a4 expression via nuclear factor-κB and sterol regulatory element-binding protein-1 in adipocytes. J Mol Endocrinol. 49, 97–106 (2012).
    Dos Santos, E. G. et al. Rapid nongenomic E2 effects on p42/p44 MAPK, activator protein-1, and cAMP response element binding protein in rat white adipocytes. Endocrinology. 143, 930–940 (2002).
    Muraki, K., Okuya, S. & Tanizawa, Y. Estrogen receptor alpha regulates insulin sensitivity through IRS-1 tyrosine phosphorylation in mature 3T3-L1 adipocytes. Endocr J. 53, 841–851 (2006).
    Xing, H. et al. TNF alpha-mediated inhibition and reversal of adipocyte differentiation is accompanied by suppressed expression of PPARgamma without effects on Pref-1 expression. Endocrinology. 138(7), 2776–2783 (1997).
    Hyder, S. M., Nawaz, Z., Chiappetta, C. & Stancel, G. M. Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor. Cancer Res. 60, 3183–3190 (2000).

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2021